The high rate of papillary thyroid cancers lacking CDH16 staining is consistent with data from Li et al.4, describing markedly lower CDH16 RNA levels in papillary carcinomas as compared to normal tissues in 505 patients from the TCGA dataset and in 16 own cases. This evidence concerns the gene CDH16 and thyroid gland papillary carcinoma.